Krsnaa Diagnostics plans to acquire a 24% stake in Apulki Healthcare, securing exclusive rights to provide diagnostic services at Apulki’s oncology and cardiology hospitals. This partnership will ensure Krsnaa’s leadership in these segments for over 30 years, offering advanced diagnostic technologies across Apulki’s planned network of hospitals in India.
Related Posts
India keeps markets guessing over MPC members
The Reserve Bank of India is approaching a crucial interest rate decision with uncertainty looming as the contracts of three external members of its monetary […]
India will work with Brazil for consensus at G20: Amitabh Kant
With rising tensions in West Asia, India’s G20 sherpa Amitabh Kant emphasized collaboration with Brazil to achieve consensus at the G20 summit. Key issues include […]